Interact with experts and peers.

Recent Posts

4 of 4 Shown
  • How I Integrate Biomarkers Into the Management of Heart Failure

    Akshay Suvas Desai MD, MPH - 10/10/2016 1 comment / Last Comment: 10/11/2016
    I describe how biomarkers such as BNP and NT-proBNP can help influence decisions about the diagnosis and prognosis of heart failure.
  • How I Use the New DAPT Score to Determine Optimal Duration of DAPT

    Christopher P. Cannon MD - 1/22/2016 3 comments / Last Comment: 8/26/2016
    Results from a recent subanalysis of the DAPT study have the potential to help clinicians address the challenging question of whether to extend DAPT duration for patients with coronary stents.
  • Antiplatelet Therapy in Peripheral Artery Disease: What I Do and Why

    Joshua A. Beckman MD - 12/9/2015 6 comments / Last Comment: 8/26/2016
    In my approach to antiplatelet therapy for patients with PAD, I maximize available data and draw from coronary guidelines when necessary.
  • Loop Diuretics in Acute Heart Failure: How I Navigate a Limited Evidence Base

    Javed Butler MD, MPH, MBA - 10/8/2015 8 comments / Last Comment: 2/14/2017
    A paucity of randomized data has led to a wide range of clinical practices regarding the delivery and dosing of loop diuretics in patients with acute heart failure. Here’s my approach.
4 of 4 Shown
Show 0 More